Related Experiment Video
Updated: Aug 14, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Hepatocyte Growth Factor in Predialysis and Hemodialysis Chronic Kidney Disease Patients
Sarat Chandra Vulugundam1, Vinapamula S Kiranmayi2, P V L N Srinivasa Rao2
1Department of Nephrology and Department of Biochemistry Andhra Pradesh, India.
Insights
Hepatocyte growth factor (HGF) levels are elevated in chronic kidney disease (CKD) patients, indicating potential as a biomarker for renal fibrosis. Levels were higher in predialysis CKD patients compared to those on dialysis.
Area of Science:
- Nephrology
- Biochemistry
- Molecular Biology
Background:
- Chronic kidney disease (CKD) is a global health issue marked by declining renal function and fibrosis.
- Hepatocyte growth factor (HGF) has demonstrated antifibrotic properties in kidney tissues.
Purpose of the Study:
- To assess Hepatocyte growth factor (HGF) levels in patients with chronic kidney disease (CKD).
- To investigate the association between HGF and markers of inflammation and oxidative stress in CKD patients.
- To evaluate HGF as a potential indicator of renal fibrosis in CKD.
Main Methods:
- Recruited 80 subjects: 20 healthy controls, 40 predialysis CKD patients (stages 1-5), and 20 dialysis CKD patients.
- Measured serum levels of HGF, high-sensitivity C-reactive protein (hsCRP), malondialdehyde (MDA), and ferric reducing ability of plasma (FRAP).
- Analyzed HGF levels in relation to CKD stage, dialysis status, and inflammatory/oxidative stress markers.
Main Results:
- HGF levels were significantly higher in all CKD patients compared to healthy controls.
- CKD patients exhibited elevated hsCRP, MDA, and FRAP levels, indicating inflammation and oxidative stress.
- HGF levels were higher in predialysis CKD patients than in dialysis patients, though not statistically significant. No significant correlation was found between HGF and the studied markers.
Conclusions:
- HGF levels increase in response to renal injury in CKD patients.
- Elevated HGF suggests a role in renal fibrosis, potentially serving as a biomarker.
- HGF levels may differentiate between predialysis and dialysis CKD stages, warranting further investigation.
Abstract:
Chronic kidney disease (CKD) which is characterized by progressive loss of renal function and renal fibrosis is a worldwide public health problem. Hepatocyte growth factor (HGF) is a polypeptide that exhibits multiple functions including antifibrotic effects on kidneys. The present study was aimed at evaluating HGF levels and studying its association with markers of inflammation and oxidative stress in patients of predialysis and dialysis CKD. A total of 80 subjects including 20 healthy controls, 40 patients of CKD stage 1 to stage 5 (predialysis), and 20 CKD patients with end-stage renal disease on hemodialysis were recruited. HGF, high-sensitivity C-reactive protein (hsCRP), malondialdehyde (MDA), and ferric reducing ability of plasma (FRAP) were measured in all the subjects. HGF levels were significantly higher in all patients with CKD compared to controls. The levels were found to be lower in patients on dialysis than in the predialysis group; however, the difference was not statistically significant. hsCRP, MDA, and FRAP were significantly higher in all patients with CKD than in controls. HGF levels did not show a significant correlation with the markers studied. HGF levels were increased in response to renal injury in CKD patients. The levels were higher in predialysis patients of CKD than in CKD patients on dialysis. HGF levels may be used as an indicator of renal fibrosis in patients with CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Chronic Kidney Disease I: Introduction
Hemodialysis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Hemodialysis III: Nursing Management

